Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Schechter

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and CameroonSwati B Gupta, Christopher T Mast, Nathan D Wolfe, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|October 5, 2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panelScott M Hammer, Michael S Saag, Mauro Schechter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2015
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled TrialKathleen Mulligan, David V Glidden, Peter L Anderson, et al.
JAMA|July 14, 2004
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA PanelPatrick G Yeni, Scott M Hammer, Martin S Hirsch, et al.
The Lancet. Infectious Diseases|July 29, 2014
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyRobert M Grant, Peter L Anderson, Vanessa McMahan, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
JAMA|July 4, 2002
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA PanelPatrick G Yeni, Scott M Hammer, Charles C J Carpenter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trialsRoy T Steigbigel, David A Cooper, Hedy Teppler, et al.
The Journal of Infectious Diseases|August 14, 2025
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIVLishomwa C Ndhlovu, Leila B Giron, Juliana Galinskas, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Pathogens & Immunity|January 31, 2022
Is France Once Again Looking for a Scapegoat?Michael M Lederman, Jeffrey S Flier, Peter Hale, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and CameroonSwati B Gupta, Christopher T Mast, Nathan D Wolfe, et al.
Topics in HIV Medicine : a Publication of the International AIDS Society, USA|October 5, 2006
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panelScott M Hammer, Michael S Saag, Mauro Schechter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2015
Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled TrialKathleen Mulligan, David V Glidden, Peter L Anderson, et al.
JAMA|July 14, 2004
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA PanelPatrick G Yeni, Scott M Hammer, Martin S Hirsch, et al.
The Lancet. Infectious Diseases|July 29, 2014
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyRobert M Grant, Peter L Anderson, Vanessa McMahan, et al.
PLOS Global Public Health|February 14, 2025
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreakVanessa Apea, Boghuma K Titanji, Francesca H Dakin, et al.
JAMA|July 4, 2002
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA PanelPatrick G Yeni, Scott M Hammer, Charles C J Carpenter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2010
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trialsRoy T Steigbigel, David A Cooper, Hedy Teppler, et al.
The Journal of Infectious Diseases|August 14, 2025
Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People Living with HIVLishomwa C Ndhlovu, Leila B Giron, Juliana Galinskas, et al.
Pageof 12